You cannot develop cystic fibrosis (CF) as an adult. It is a genetic condition present from birth, caused by inheriting two copies of a mutated gene, one from each biological parent. However, roughly 7 to 9% of new CF diagnoses are made in adults, sometimes as late as the 50s or 60s. These individuals have had CF their entire lives but carried mutations mild enough that symptoms were subtle, misdiagnosed, or overlooked for decades.
Why CF Is Always Present From Birth
CF is caused by mutations in a gene that controls how salt and water move across cell surfaces. When this gene doesn’t work properly, the body produces abnormally thick, sticky mucus that clogs the lungs, pancreas, and other organs. Every person inherits two copies of this gene, one from each parent. You need two faulty copies to have CF. If you inherit only one, you’re a carrier with no symptoms. This inheritance pattern is locked in at conception, so there is no way to “catch” or develop CF later in life from an infection, environmental exposure, or lifestyle factor.
How Adults End Up With a New Diagnosis
The gene responsible for CF can be mutated in hundreds of different ways, and these mutations vary enormously in severity. The most common mutations cause the classic childhood presentation: chronic cough, frequent lung infections, poor growth, and digestive problems. But milder mutations leave the gene partially functional, producing enough normal protein that the body compensates for years.
One well-documented example is a splicing mutation called 3849+10KbC>T, which allows the body to produce some working protein. People with this type of mutation often have no pancreatic problems and only mild respiratory symptoms, so they slip through standard screening. In one published case, a patient wasn’t diagnosed until age 58. In another, a woman reached 57 before recurrent bronchitis and pneumonia finally led to testing. Both had been living with CF their entire lives without knowing it.
Newborn screening, which is now standard across the U.S. and Canada, catches most cases early. But screening wasn’t widely implemented until the 2000s and 2010s, meaning many adults alive today were born before it existed. Even current screening can miss patients whose mutations result in residual gene function, because the initial blood test may come back falsely negative.
Symptoms That Trigger a Late Diagnosis
Adults diagnosed with CF typically have what’s called an “atypical” presentation. Instead of the severe, multi-organ disease seen in children, they may have problems in just one or two systems, and those problems often mimic more common conditions.
- Respiratory: Chronic sinusitis, recurring nasal polyps, a productive cough that won’t resolve, recurrent pneumonia, or lung obstruction previously labeled as asthma or COPD.
- Digestive: Chronic constipation or diarrhea, unexplained bouts of pancreatitis, difficulty maintaining weight, or nutritional deficiencies. Unlike the severe pancreatic failure seen in childhood CF, digestive symptoms in late-diagnosed adults are often subtle.
- Reproductive: Male infertility is a surprisingly common clue. Between 50 and 83% of men born without the vas deferens (the tube that carries sperm) carry at least one CF gene mutation. In some men, infertility is the only sign of the disease.
A pattern that should raise suspicion is any combination of these: a long history of sinus problems or nasal polyps, lungs that don’t respond well to standard asthma treatments, and unexplained fertility trouble. One case study described a 43-year-old woman whose medical history included asthma, chronic sinusitis, nasal surgery, environmental allergies, and infertility, all of which turned out to be linked to CF.
How CF Is Confirmed in Adults
The primary diagnostic tool is the sweat chloride test. People with CF have unusually salty sweat because the faulty gene disrupts salt transport. A sweat chloride level above 60 mmol/L confirms CF. Levels between 40 and 60 mmol/L are considered borderline and warrant further investigation. Below 40 is normal. These thresholds apply regardless of age.
If the sweat test is borderline or inconclusive, genetic testing can identify specific mutations. This is particularly useful for adults with mild disease, since their sweat chloride levels sometimes fall in the borderline range rather than clearly above 60. Finding two CF-causing mutations on genetic testing confirms the diagnosis even when other tests are ambiguous.
Why Adults With CF Often Have Milder Disease
About 75% of infants diagnosed with CF already have significant pancreatic damage at the time of diagnosis, meaning their pancreas can’t produce enough digestive enzymes. Infants carrying two severe mutations typically show measurable pancreatic problems within three to four months of life. Adults diagnosed later, by contrast, often have at least one mild mutation that preserves partial organ function. Many retain full pancreatic function and never develop the malabsorption or growth problems associated with classic childhood CF.
This doesn’t mean late-diagnosed CF is harmless. Lung damage accumulates over time, and years of unrecognized disease can take a toll. But the overall trajectory tends to be slower, and single-organ involvement is more common. Some patients reach their diagnosis with only chronic sinusitis and nasal polyps, while their lungs remain relatively preserved.
Treatment Options for Late-Diagnosed Adults
The treatment landscape for CF has transformed in recent years with the arrival of drugs that target the underlying protein defect rather than just managing symptoms. These medications, called CFTR modulators, help the faulty protein work more effectively.
The triple-combination therapy known as Trikafta (approved in 2019 for patients 12 and older) has shown significant results. In clinical trials involving adults, lung function improved by nearly 14 percentage points compared to placebo over treatment periods longer than eight weeks. A newer once-daily option called Alyftrek was recently approved by the FDA for people six and older, covering the same mutations as Trikafta plus 31 additional rare mutations. Both therapies also substantially reduce sweat chloride levels and improve quality-of-life scores.
For adults who’ve lived decades without knowing they had CF, starting modulator therapy can be a turning point. These drugs work best when there’s still residual protein function, which is exactly the situation most late-diagnosed adults are in. Beyond modulators, standard CF care includes airway clearance techniques, inhaled treatments to thin mucus, and close monitoring for lung infections and nutritional status.
What a Late Diagnosis Means Long Term
Being diagnosed with CF as an adult can feel disorienting, but it generally carries a better prognosis than a childhood diagnosis. The mutations behind late-onset disease are inherently milder, organ damage has progressed more slowly, and modern therapies are highly effective for these genetic profiles. Many late-diagnosed patients have already lived well into middle age or beyond before their diagnosis, which itself reflects the relatively preserved function of their organs.
The bigger risk is staying undiagnosed. Without treatment, lung infections gradually cause irreversible scarring, and nutritional deficits can quietly worsen. Adults with unexplained chronic respiratory symptoms, recurring pancreatitis, or male infertility due to absent vas deferens have good reason to ask about CF testing, even if the diagnosis seems unlikely at their age.